this is vyramed

we work for a better future:

Our goal is to bring knowledge, data & support to the healthcare industry. With over 50 years of combined experience in the field, we use our technical & medical expertise to bring forward impactful results.

VyraMed is a product of FetTech.

Adaptable

Can be used in conjunction with other therapies

Safe

The MTP Platform technology has been used clinically on thousands of patients with no reported adverse events 

Natural

Made only of natural components

discover the unlimited potential!

  • topical gel application

    Future products can be used for localized viral infections like cold sores, rashes and shingles.

    Topical gel antiviral application is simple: clean the affected area, use a clean applicator or finger, apply a thin layer, and gently rub it in.

  • Intravenous Application

    Future products can be applied for the treatment of HIV, hepatitis, rubella, and Rabies.

    Intravenous administration of antivirals involves delivering the product directly into the bloodstream for rapid onset of action against bloodborne viruses.

  • House Disinfectant application

    Future products can be applied in household disinfectants to deactivate viruses on treated surfaces.

    Household disinfectants work through mechanisms such as protein denaturation, lipid envelope disruption, oxidative damage to genetic material, or blocking viral attachment to surfaces.

  • nasal spray application

    Future products can be delivered into the nasal passages for anti-viral applications related to Influenza, Coronavirus, MERS, SARS.

    Antiviral nasal sprays inactivate viral particles in the nasal passages, reducing viral infection and/or spread.

  • Nebulizer Application

    Future products can be used in nebulizer applications to treat viruses like influenza and coronavirus.

    Nebulizers turn liquids into a fine mist for inhalation, effectively reaching the respiratory tract to target and inhibit respiratory viruses.

  • eye drops application

    Future products can be used to treat ocular infections caused by herpes simplex virus (HSV).

    Antiviral eye drops inactivate viruses within the eye, treating viral eye infections.

  • other applications

    Our innovative antiviral can be used in conjunction with other therapies.

    Do you want to be part of the driving force of unleashing new opportunities?

    Join us as a development partner and set the scene for the future of antivirals.

our story

Early in the development of our first regenerative medicine product, we discovered that the Multi-Tissue Platform (MTP) had anti-viral activity against enveloped viruses. 

During the pandemic we refocused our efforts on exploring the antiviral nature of our technology. 

This has led to the development of different forms of the MTP technology, such as a powder, gel, and liquid; which all maintained the anti-viral activity. 

We continue to research the anti-viral nature of the MTP technology and we’re excited to share our results and progress!

2013 - the beginning of Fettech

Danielle and Clay embarked on their journey with a vision to enhance and expand medical knowledge and innovation.

2015 - VyraMed discovery

During development of our MTP technology, we discovered it has anti-viral activity.

2019 - Pandemic begins

The COVID-19 pandemic emerged, increasing our focus and priority on development efforts for anti-viral applications.

2020 - MTP technology expanded anti-viral test data

Test results demonstrate efficacy of the MTP technology against a wide variety of enveloped viruses, including herpes, HIV, West Nile, poxviruses, coronavirus, influenza, hepatitis, rubella, and rabies.

2023 - a revolutionary breakthrough in anti-viral applications

Coming soon!